Case Report/Case Series |

Does a Positive Pittsburgh Compound B Scan in a Patient With Dementia Equal Alzheimer Disease?

Simon Ducharme, MD, MSc1,2; Marie-Christine Guiot, MD, FRCPC3; James Nikelski, PhD4; Howard Chertkow, MD, FRCPC3,4
[+] Author Affiliations
1Department of Neurology, Massachusetts General Hospital and McLean Hospital, Harvard University, Boston
2Department of Psychiatry, McGill University, Montreal, Quebec, Canada
3Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada
4Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
JAMA Neurol. 2013;70(7):912-914. doi:10.1001/jamaneurol.2013.420.
Text Size: A A A
Published online

Importance  The clinical role of amyloid brain positron emission tomographic imaging in the diagnosis of Alzheimer disease is currently being formulated. The specificity of a positive amyloid scan is a matter of contention.

Observations  An 83-year-old Canadian man presented with a 5-year history of predominantly short-term memory loss and functional impairment. Clinical evaluation revealed significant, gradually progressive short-term memory loss in the absence of any history of strokes or other neuropsychiatric symptoms. The patient met clinical criteria for probable Alzheimer disease but had a higher than expected burden of white matter disease on magnetic resonance imaging. A positron emission tomographic Pittsburgh Compound B scan was highly positive in typical Alzheimer disease distribution. The patient died of an intracerebral hemorrhage 6 months after the assessment. Autopsy revealed cerebral amyloid angiopathy in the complete absence of amyloid plaques or neurofibrillary tangles.

Conclusions and Relevance  This patient demonstrates that a positive Pittsburgh Compound B scan in a patient with clinical dementia meeting criteria for probable Alzheimer disease is not proof of an Alzheimer disease pathophysiological process. A positive Pittsburgh Compound B scan in typical Alzheimer disease distribution in a patient with dementia can be secondary to cerebral amyloid angiopathy alone.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours


Place holder to copy figure label and caption
Figure 1.
Magnetic Resonance Image and Positron Emission Tomographic Scan

A, Axial T2-weighted magnetic resonance imaging showing prominent periventricular white matter changes. B, Positive carbon 11–labeled Pittsburgh Compound B positron emission tomographic scan showing β-amyloid (light color) in typical Alzheimer disease distribution, superimposed on a 3-dimensional rendering of the patient’s structural magnetic resonance image (dark color).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Postmortem Immunohistochemistry for β-Amyloid in the Occipital Lobe

Absence of positive amyloid plaques and presence of numerous intraparenchymal cortical and subarachnoid vessels demonstrated strong positivity for β-amyloid (clone 6F/3D [Dako Corp], original magnification ×20).

Graphic Jump Location




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics

Users' Guides to the Medical Literature
Clinical Resolution

Users' Guides to the Medical Literature
Clinical Scenario